Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pazdur

Showing results (91-100 of 151) with videos related to

Pageof 16
Sort By:
Anticancer Research|March 1, 1993
Clinical pharmacology of 11-acetyl-8-carbamoyloxymethyl-4-formyl-14-oxa-1,11-diazatetracyclo (7.4.1.0(2,7).0(10,12) tetradeca-2,4,6-trien-6,9-diyl diacetate (FK 973)D H Ho, R Pazdur, N S Brown, et al.
American Journal of Clinical Oncology|February 24, 2001
Phase II study of intravenous CI-958 in metastatic colorectal adenocarcinomaP M Hoff, J A Ellerton, S R Dakhil, et al.
Gynecologic Oncology|August 1, 1981
Neuroendocrine carcinoma of the cervix: implications for staging and therapyR Pazdur, P Bonomi, R Slayton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1985
Effect of initial resection of small-cell carcinoma of the lung: a review of Southwest Oncology Group Study 7628G G Friess, J D McCracken, M L Troxell, et al.
American Journal of Clinical Oncology|December 1, 1995
Pilot phase II trial of 13-cis-retinoic acid and interferon-alpha combination therapy for advanced pancreatic adenocarcinomaD F Moore, R Pazdur, S Sugarman, et al.
Investigational New Drugs|January 1, 1996
Phase II trial of ZD1694 (Tomudex) in patients with advanced pancreatic cancerR Pazdur, N J Meropol, E S Casper, et al.
Anti-Cancer Drugs|November 21, 1998
Pharmacokinetics of recombinant human interferon-alpha 2a combined with 5-fluorouracil in patients with advanced colorectal carcinomaJ Kim, J Zhi, H Satoh, et al.
American Journal of Clinical Oncology|October 1, 1995
Phase II trial of isotretinoin and recombinant interferon alfa-2a in metastatic colorectal carcinomaR Pazdur, B Bready, J A Ajani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2001
Effect of food on the oral bioavailability of UFT and leucovorin in cancer patientsB Damle, F Ravandi, S Kaul, et al.
Investigational New Drugs|January 1, 1994
Phase II trial of piroxantrone in metastatic gastric adenocarcinomaR Pazdur, B Bready, A J Scalzo, et al.
Pageof 16

Showing results (91-100 of 151) with videos related to

Sort By:
Pageof 16
Anticancer Research|March 1, 1993
Clinical pharmacology of 11-acetyl-8-carbamoyloxymethyl-4-formyl-14-oxa-1,11-diazatetracyclo (7.4.1.0(2,7).0(10,12) tetradeca-2,4,6-trien-6,9-diyl diacetate (FK 973)D H Ho, R Pazdur, N S Brown, et al.
American Journal of Clinical Oncology|February 24, 2001
Phase II study of intravenous CI-958 in metastatic colorectal adenocarcinomaP M Hoff, J A Ellerton, S R Dakhil, et al.
Gynecologic Oncology|August 1, 1981
Neuroendocrine carcinoma of the cervix: implications for staging and therapyR Pazdur, P Bonomi, R Slayton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1985
Effect of initial resection of small-cell carcinoma of the lung: a review of Southwest Oncology Group Study 7628G G Friess, J D McCracken, M L Troxell, et al.
American Journal of Clinical Oncology|December 1, 1995
Pilot phase II trial of 13-cis-retinoic acid and interferon-alpha combination therapy for advanced pancreatic adenocarcinomaD F Moore, R Pazdur, S Sugarman, et al.
Investigational New Drugs|January 1, 1996
Phase II trial of ZD1694 (Tomudex) in patients with advanced pancreatic cancerR Pazdur, N J Meropol, E S Casper, et al.
Anti-Cancer Drugs|November 21, 1998
Pharmacokinetics of recombinant human interferon-alpha 2a combined with 5-fluorouracil in patients with advanced colorectal carcinomaJ Kim, J Zhi, H Satoh, et al.
American Journal of Clinical Oncology|October 1, 1995
Phase II trial of isotretinoin and recombinant interferon alfa-2a in metastatic colorectal carcinomaR Pazdur, B Bready, J A Ajani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2001
Effect of food on the oral bioavailability of UFT and leucovorin in cancer patientsB Damle, F Ravandi, S Kaul, et al.
Investigational New Drugs|January 1, 1994
Phase II trial of piroxantrone in metastatic gastric adenocarcinomaR Pazdur, B Bready, A J Scalzo, et al.
Pageof 16